v3.24.1.u1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Public Offering
Ordinary Shares
Ordinary Shares
Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Public Offering
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022     52,103,608        
Beginning balance at Dec. 31, 2022 $ 622,042   $ 521   $ 1,454,524   $ (833,003)
Share-based compensation 8,790       8,790    
Issuance of ordinary shares upon exercise of stock options (in shares)     179,474        
Issuance of ordinary shares upon exercise of stock options 2,540   $ 2   2,538    
Issuance of ordinary shares (in shares)       395,096      
Issuance of ordinary shares, net of issuance costs   $ 20,901   $ 4   $ 20,897  
Net income (loss) (46,864)           (46,864)
Ending balance (in shares) at Mar. 31, 2023     52,678,178        
Ending balance at Mar. 31, 2023 607,409   $ 527   1,486,749   (879,867)
Stock Issuance Costs   $ (1,400)          
Beginning balance (in shares) at Dec. 31, 2023     53,682,117        
Beginning balance at Dec. 31, 2023 561,365   $ 537   1,540,859   (980,031)
Share-based compensation $ 12,383       12,383    
Issuance of ordinary shares upon exercise of stock options (in shares) 38,338   38,338        
Issuance of ordinary shares upon exercise of stock options $ 890   $ 0   890    
Net income (loss) (72,239)           (72,239)
Ending balance (in shares) at Mar. 31, 2024     53,720,455        
Ending balance at Mar. 31, 2024 $ 502,399   $ 537   $ 1,554,132   $ (1,052,270)